267 related articles for article (PubMed ID: 26918001)
1. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids.
Brölmann H; Bongers M; Garza-Leal JG; Gupta J; Veersema S; Quartero R; Toub D
Gynecol Surg; 2016; 13():27-35. PubMed ID: 26918001
[TBL] [Abstract][Full Text] [Related]
2. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate® System: three- and six-month endpoint results from the FAST-EU study.
Bongers M; Brölmann H; Gupta J; Garza-Leal JG; Toub D
Gynecol Surg; 2015; 12(1):61-70. PubMed ID: 25774122
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Clinical Outcomes of Transcervical Radiofrequency Ablation of Uterine Fibroids: The VITALITY Study.
Garza-Leal JG
J Gynecol Surg; 2019 Feb; 35(1):19-23. PubMed ID: 30713407
[No Abstract] [Full Text] [Related]
4. Transcervical fibroid ablation with the Sonata™ system for treatment of submucous and large uterine fibroids.
Shifrin G; Engelhardt M; Gee P; Pschadka G
Int J Gynaecol Obstet; 2021 Oct; 155(1):79-85. PubMed ID: 33544889
[TBL] [Abstract][Full Text] [Related]
5. Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results.
Christoffel L; Römer T; Schiermeier S
Med Devices (Auckl); 2021; 14():77-84. PubMed ID: 33688276
[TBL] [Abstract][Full Text] [Related]
6. Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata.
Lukes A; Green MA
J Gynecol Surg; 2020 Oct; 36(5):228-233. PubMed ID: 33061253
[No Abstract] [Full Text] [Related]
7. The INTEGRITY Trial: Preservation of Uterine-Wall Integrity 12 Months After Transcervical Fibroid Ablation with the Sonata System.
Bongers M; Gupta J; Garza-Leal JG; Brown M; Felberbaum R
J Gynecol Surg; 2019 Oct; 35(5):299-303. PubMed ID: 31602171
[No Abstract] [Full Text] [Related]
8. A New Paradigm for Uterine Fibroid Treatment: Transcervical, Intrauterine Sonography-Guided Radiofrequency Ablation of Uterine Fibroids with the Sonata System.
Toub DB
Curr Obstet Gynecol Rep; 2017; 6(1):67-73. PubMed ID: 28357157
[TBL] [Abstract][Full Text] [Related]
9. What predicts durable symptom relief of uterine fibroids treated with MRI-guided focused ultrasound? A multicenter trial in 8 academic centers.
Bitton RR; Fast A; Vu KN; Lum DA; Chen B; Hesley GK; Raman SS; Matsumoto AH; Price TM; Tempany C; Dhawan N; Dolen E; Kohi M; Fennessey FM; Ghanouni P
Eur Radiol; 2023 Nov; 33(11):7360-7370. PubMed ID: 37553488
[TBL] [Abstract][Full Text] [Related]
10. Transcervical Radiofrequency Ablation of Symptomatic Uterine Fibroids: 2-Year Results of the SONATA Pivotal Trial.
Miller CE; Osman KM
J Gynecol Surg; 2019 Dec; 35(6):345-349. PubMed ID: 32226268
[No Abstract] [Full Text] [Related]
11. 12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids.
Hudgens J; Johns DA; Lukes AS; Forstein DA; Delvadia D
Int J Womens Health; 2019; 11():387-394. PubMed ID: 31308763
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the Sonata System: a retrospective follow-up study.
van der Meulen JF; Cooijmans TH; van Zutven VJ; Leemans JC; Verhoeven CJ; Bongers MY
AJOG Glob Rep; 2022 Nov; 2(4):100087. PubMed ID: 36536842
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas.
Fasciani A; Turtulici G; Siri G; Ferrero S; Sirito R
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32178351
[No Abstract] [Full Text] [Related]
14. Ultrasound guided percutaneous radiofrequency thermal ablation of symptomatic uterine fibroids - results from a single center and 52 weeks of follow up.
Yüce G; Tayarer A; Keskin HL; Genc B; Canyigit M
Ginekol Pol; 2020; 91(8):447-452. PubMed ID: 32902841
[TBL] [Abstract][Full Text] [Related]
15. Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids.
Al-Hendy A; Bradley L; Owens CD; Wang H; Barnhart KT; Feinberg E; Schlaff WD; Puscheck EE; Wang A; Gillispie V; Hurtado S; Muneyyirci-Delale O; Archer DF; Carr BR; Simon JA; Stewart EA
Am J Obstet Gynecol; 2021 Jan; 224(1):72.e1-72.e50. PubMed ID: 32702363
[TBL] [Abstract][Full Text] [Related]
16. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies.
Bradley LD; Pasic RP; Miller LE
J Laparoendosc Adv Surg Tech A; 2019 Dec; 29(12):1507-1517. PubMed ID: 31702440
[No Abstract] [Full Text] [Related]
17. Uterine Myoma Position-based Radiofrequency Ablation (UMP-b RFA): 36 months follow-up clinical outcomes.
Fasciani A; Turtulici G; Pedullà A; Sirito R
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():23-28. PubMed ID: 36527825
[TBL] [Abstract][Full Text] [Related]
18. The effect of transcervical resection of submucous fibroids on menstrual blood loss: A prospective cohort study.
Keizer AL; Jacobs BL; Thurkow AL; de Lange ME; Radder CM; van Kesteren PJM; Hanstede MMF; Huirne JAF; Hehenkamp WJK
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():128-135. PubMed ID: 35640441
[TBL] [Abstract][Full Text] [Related]
19. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
20. Improvement of fibroid-associated symptoms and quality of life after US-guided high-intensity focused ultrasound (HIFU) of uterine fibroids.
Tonguc T; Recker F; Ganslmeier J; Strunk HM; Pieper CC; Ramig O; Welz S; Egger EK; Mutschler N; Warwas L; Essler M; Mustea A; Conrad R; Marinova M
Sci Rep; 2022 Dec; 12(1):21155. PubMed ID: 36476975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
